CHARTWELL INVESTMENT PARTNERS, LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
CHARTWELL INVESTMENT PARTNERS, LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,724,000
+81.1%
98,1770.0%0.05%
+92.9%
Q2 2021$952,000
-8.9%
98,177
+0.9%
0.03%
-9.7%
Q1 2021$1,045,000
-30.7%
97,296
-5.1%
0.03%
-35.4%
Q4 2020$1,508,000
-15.8%
102,524
-18.7%
0.05%
-27.3%
Q3 2020$1,792,000
+119.3%
126,085
+24.8%
0.07%
+106.2%
Q2 2020$817,000100,9920.03%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders